Published in J Med Chem on September 29, 1995
6-Bromo-3-methyl-2-phenyl-3H-imidazo[4,5-b]pyridine. Acta Crystallogr Sect E Struct Rep Online (2011) 0.86
1-Acetyl-6-bromo-1H-imidazo[4,5-b]pyridin-2(3H)-one. Acta Crystallogr Sect E Struct Rep Online (2011) 0.75
Digital holography for quantitative phase-contrast imaging. Opt Lett (1999) 3.10
Sources of absorption and scattering contrast for near-infrared optical mammography. Acad Radiol (2001) 2.66
Spectroscopy enhances the information content of optical mammography. J Biomed Opt (2002) 1.83
Competitive and selective antagonism of P2Y1 receptors by N6-methyl 2'-deoxyadenosine 3',5'-bisphosphate. Br J Pharmacol (1998) 1.80
A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolate. J Virol (1995) 1.71
Aloe-emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors. Cancer Res (2000) 1.71
Circulating endothelial progenitor cells in subjects with erectile dysfunction. Int J Impot Res (2005) 1.65
Perturbation Monte Carlo methods to solve inverse photon migration problems in heterogeneous tissues. Opt Lett (2001) 1.61
Human P2Y1 receptor: molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites. J Med Chem (1998) 1.61
A potential role for the vanilloid receptor TRPV1 in the therapeutic effect of curcumin in dinitrobenzene sulphonic acid-induced colitis in mice. Neurogastroenterol Motil (2007) 1.56
2-Chloro-N6-cyclopentyladenosine: a highly selective agonist at A1 adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol (1988) 1.47
Adenosine deaminase: functional implications and different classes of inhibitors. Med Res Rev (2001) 1.46
The role of soda lime during administration of inhaled nitric oxide. Br J Anaesth (1994) 1.43
Human cytomegalovirus and restenosis of the internal carotid artery. Stroke (1996) 1.43
Factors affecting contraceptive use in Pakistan. Pak Dev Rev (1996) 1.42
Early and rapid diagnosis of CMV infection by nonradioactive in situ hybridization in pediatric kidney transplant recipients. Nephron (1992) 1.39
Assessment of left ventricular performance during laparoscopy. Eur Rev Med Pharmacol Sci (2014) 1.38
Peptidyl anthraquinones as potential antineoplastic drugs: synthesis, DNA binding, redox cycling, and biological activity. J Med Chem (1996) 1.29
Structure-activity relationships of bisphosphate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists. J Med Chem (1999) 1.25
West Nile virus transmission with human cases in Italy, August - September 2009. Euro Surveill (2009) 1.18
2-Chloro-N6-[3H]cyclopentyladenosine ([3H]CCPA)--a high affinity agonist radioligand for A1 adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol (1989) 1.16
Antiviral properties of deazaadenine nucleoside derivatives. Curr Med Chem (2006) 1.14
Quantifying the absorption and reduced scattering coefficients of tissuelike turbid media over a broad spectral range with noncontact Fourier-transform hyperspectral imaging. Appl Opt (2000) 1.13
Photoaffinity labeling of A1-adenosine receptors. J Biol Chem (1985) 1.11
Protection against oxidative damage and cell death by the natural antioxidant ergothioneine. Food Chem Toxicol (1999) 1.09
Expression of cytokeratin 20 redefines urothelial papillomas of the bladder. Lancet (1999) 1.09
An evaluation of the antioxidant and antiviral action of extracts of rosemary and Provençal herbs. Food Chem Toxicol (1996) 1.08
Multimeric self-assembly equilibria involving the histone-like protein H-NS. A thermodynamic study. J Biol Chem (2000) 1.06
User's guide to some new tests for hepatitis-B antigen. Lancet (1974) 1.05
Separation methods for acyclovir and related antiviral compounds. J Chromatogr B Biomed Sci Appl (2001) 1.04
A2A adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists. Curr Pharm Des (2008) 1.04
Role of multivesicular bodies and their components in the egress of enveloped RNA viruses. Rev Med Virol (2009) 1.04
Genome sequence analysis of the first human West Nile virus isolated in Italy in 2009. Euro Surveill (2009) 1.03
Anti-HIV-1 activity of chemically modified heparins: correlation between binding to the V3 loop of gp120 and inhibition of cellular HIV-1 infection in vitro. Biochemistry (1994) 1.03
Intranuclear delivery of an antiviral peptide mediated by the B subunit of Escherichia coli heat-labile enterotoxin. Proc Natl Acad Sci U S A (1999) 1.03
On the mechanism of action of quinolone drugs. Trends Microbiol (1993) 0.96
Increased risk of NASH in patients carrying the C(-159)T polymorphism in the CD14 gene promoter region. Gut (2006) 0.96
CX3CL1-induced modulation at CA1 synapses reveals multiple mechanisms of EPSC modulation involving adenosine receptor subtypes. J Neuroimmunol (2010) 0.95
A prospective study of BK-virus-associated haemorrhagic cystitis in paediatric patients undergoing allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant (2007) 0.95
HIV coreceptor tropism in paired plasma, peripheral blood mononuclear cell, and cerebrospinal fluid isolates from antiretroviral-naïve subjects. J Clin Microbiol (2011) 0.94
Clinical and virological findings in the ongoing outbreak of West Nile virus Livenza strain in northern Italy, July to September 2012. Euro Surveill (2012) 0.94
2-Alkynyl derivatives of adenosine and adenosine-5'-N-ethyluronamide as selective agonists at A2 adenosine receptors. J Med Chem (1992) 0.93
2-Alkynyl derivatives of adenosine-5'-N-ethyluronamide: selective A2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation. J Med Chem (1994) 0.93
HSV-2 specific seroprevalence among various populations in Rome, Italy. The Italian Herpes Management Forum. Sex Transm Infect (2000) 0.93
Effects of CD4 synthetic peptides on HIV type I envelope glycoprotein function. J Immunol (1992) 0.92
Viral load in HCV RNA-positive pregnant women. Am J Gastroenterol (2001) 0.92
Urinary JCV-DNA testing during natalizumab treatment may increase accuracy of PML risk stratification. J Neuroimmune Pharmacol (2012) 0.91
Inhibition of platelet aggregation by adenosine receptor agonists. Naunyn Schmiedebergs Arch Pharmacol (1994) 0.91
Herpes simplex virus chronically infected human T lymphocytes are susceptible to HIV-1 superinfection and support HIV-1 pseudotyping. J Acquir Immune Defic Syndr (1999) 0.91
Introduction of alkynyl chains on C-8 of adenosine led to very selective antagonists of the A(3) adenosine receptor. Bioorg Med Chem Lett (2001) 0.91
Adenosine receptor agonists: synthesis and biological evaluation of 1-deaza analogues of adenosine derivatives. J Med Chem (1988) 0.90
Engineered E. coli delivers therapeutic genes to the colonic mucosa. Gene Ther (2005) 0.90
T-cell engineering by a chimeric T-cell receptor with antibody-type specificity for the HIV-1 gp120. Gene Ther (2005) 0.90
A point mutation in the thymidine kinase gene is responsible for acyclovir-resistance in herpes simplex virus type 2 sequential isolates. Virus Res (1992) 0.90
Rapid diagnosis of influenza type A infection: comparison of shell-vial culture, directigen flu-A and enzyme-linked immunosorbent assay. New Microbiol (1996) 0.90
Improved synthesis and antitumor activity of 1-deazaadenosine. J Med Chem (1987) 0.90
Binding of hirudin to human alpha, beta and gamma-thrombin. A comparative kinetic and thermodynamic study. J Mol Biol (1992) 0.89
[Choroidal miliary tuberculosis: fluoroangiographic study (author's transl)]. Ophthalmologica (1982) 0.89
Long-lasting neuroprotection and neurological improvement in stroke models with new, potent and brain permeable inhibitors of poly(ADP-ribose) polymerase. Br J Pharmacol (2012) 0.89
Clustering and risk factors of methicillin-resistant Staphylococcus aureus carriage in two Italian long-term care facilities. Infection (2008) 0.88
[Bone choristoma of the bilateral choroid and asymmetric microphthalmia]. J Fr Ophtalmol (1988) 0.88
Measles in Italy, July 2009 to September 2010. Euro Surveill (2011) 0.88
New substituted 9-alkylpurines as adenosine receptor ligands. Bioorg Med Chem (1998) 0.88
Thymoquinone, a potential therapeutic agent of Nigella sativa, binds to site I of human serum albumin. Phytomedicine (2010) 0.87
The catalytic subunit of herpes simplex virus type 1 DNA polymerase contains a nuclear localization signal in the UL42-binding region. Virology (2000) 0.87
Antiviral activity of gyrase inhibitors norfloxacin, coumermycin A1 and nalidixic acid. Biochem Pharmacol (1988) 0.87
Interaction of Hsp90 with 20S proteasome: thermodynamic and kinetic characterization. Proteins (2002) 0.87
Inhibitors of HIV-1 Tat-mediated transactivation. Curr Med Chem (2006) 0.87
IL-10 gene promoter and intron polymorphisms and changes in IL-10 secretion in women with idiopathic recurrent miscarriage. Hum Reprod (2014) 0.87
Simultaneous polymerase chain reaction detection and restriction typing for the diagnosis of human genital papillomavirus infection. J Virol Methods (1995) 0.87
Nonenzymatic reduction of thymoquinone in physiological conditions. Free Radic Res (2007) 0.87
Outbreak of serogroup C meningococcal disease in Veneto region, Italy. Euro Surveill (2008) 0.86
Accurate human papillomavirus genotyping by 454 pyrosequencing. Clin Microbiol Infect (2013) 0.86
Effect of neurotoxic metal ions on the proteolytic activities of the 20S proteasome from bovine brain. J Biol Inorg Chem (2002) 0.86
Phytochemical and antioxidant analysis of eight Hypericum taxa from Central Italy. Fitoterapia (2007) 0.86
Assessment of the lightcycler PCR assay for diagnosis of invasive aspergillosis in paediatric patients with onco-haematological diseases. Mycoses (2008) 0.86
Specific inhibition of herpes virus replication by receptor-mediated entry of an antiviral peptide linked to Escherichia coli enterotoxin B subunit. Proc Natl Acad Sci U S A (1994) 0.86
Molecular analysis of CDKN1C and TP53 in sporadic adrenal tumors. Eur J Endocrinol (2001) 0.86
Strategies for inhibiting function of HIV-1 accessory proteins: a necessary route to AIDS therapy? Curr Med Chem (2009) 0.86
Clinical trials of gene therapy, virotherapy, and immunotherapy for malignant gliomas. Cancer Gene Ther (2006) 0.86
Metabotropic glutamate receptors: structure and new subtype-selective ligands. Farmaco (2001) 0.86
Constituents of Eriobotrya japonica. A study of their antiviral properties. J Nat Prod (1992) 0.85
Oncolysis of pancreatic tumour cells by a gamma34.5-deleted HSV-1 does not rely upon Ras-activation, but on the PI 3-kinase pathway. Gene Ther (2006) 0.85
Constituents of Ardisia japonica and their in vitro anti-HIV activity. J Nat Prod (1996) 0.84
Antiviral activity of natural and semi-synthetic chromone alkaloids. Antiviral Res (1994) 0.84
Anti-(human immunodeficiency virus) activity of polyoxotungstates and their inhibition of human immunodeficiency virus reverse transcriptase. Biochem J (1995) 0.84